Highlights and Quick Summary
- Annual 5Y Operating CF Growth (CAGR) for 2021 was -16.33% (a -10.91% decrease from previous year)
- Annual 5Y Operating CF Growth (CAGR) for 2020 was -18.33% (a 1789.69% increase from previous year)
- Annual 5Y Operating CF Growth (CAGR) for 2019 was -0.97% (a -114.33% decrease from previous year)
Visit stockrow.com/ANIK
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical 5Y Operating CF Growth (CAGR) of Anika Therapeutics Inc.
Most recent 5Y Operating CF Growth (CAGR)of ANIK including historical data for past 10 years.Interactive Chart of 5Y Operating CF Growth (CAGR) of Anika Therapeutics Inc.
Anika Therapeutics Inc. 5Y Operating CF Growth (CAGR) for the past 10 Years (both Annual and Quarterly)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2021 | – | – | – | – | -16.33% |
2020 | – | – | – | – | -18.33% |
2019 | – | – | – | – | -0.97% |
2018 | – | – | – | – | 6.77% |
2017 | – | – | – | – | 31.07% |
2016 | – | – | – | – | 19.52% |
2015 | – | – | – | – | 22.44% |
2014 | – | – | – | – | 0.98% |
2013 | – | – | – | – | -6.34% |
2012 | – | – | – | – | -23.71% |
2011 | – | – | – | – | -16.08% |
Business Profile of Anika Therapeutics Inc.
Sector: Healthcare
Industry: Medical Devices